Four in production today. Two in development, and we say which is which.
Sterile single-use devices across infusion therapy, nephrology and dialysis, oncology, critical care and cardiac surgery — twenty-six of them licensed under our own name.
Moulded, assembled, leak-tested, packed and sterilised on the same line, inside ISO Class 7 and 8 cleanrooms classified to ISO 14644-1, under one device master record.
Child-resistant closures from 24 to 53 mm at up to 32 cavity, 13 and 20 mm flip-off seals at 48 cavity, ophthalmic nozzles, droppers, unscrewing caps and blood-collection tubes.
Cycle times from seven seconds, on moulds we designed and cut ourselves.
Dosing and dispensing componentry, closures, and elastomeric infusion pumps in CBI and PCA configurations from 50 to 300 ml.
Pilot work is under way on syringe barrels and assemblies. Auto-injectors and inhalers are a stated ambition, not a current capability.
Diagnostic and laboratory consumables and device componentry — moulded and assembled inside the controlled environment, with the same documentation discipline as a licensed device.
Microfluidic cartridges and rapid-test componentry are areas we are actively developing with partners.
We would rather tell you what we do not make yet than find out together, six months into a programme.
Today we make precision rigid parts — connectors, fittings and clamps for single-use assemblies.
Not yet: bag manufacturing, TPE tubing extrusion, aseptic connector manufacture or GMP-grade polymer film. These are the next build.
Single-use fluid-path parts for upstream and downstream bioprocess, built on our extrusion and precision moulding.
In progress: biocompatibility studies, USP Class VI qualification and mechanical and analytical testing.